Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CP.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.25ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.25NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.18ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.18NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.4.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.4.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.17ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.17NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16984.7China
BA.5.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CR.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CR.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CR.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CR.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.2.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16811.6China
BQ.1.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.2.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.27ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used